BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cambridge Laboratories Limited 

Deltic House
Kingfisher Way

Silverlink Business Park
Tyne & Wear    NE28 9NX  United Kingdom
Phone: 44-0-191-296-9369 Fax: 44-0-191-296-9368


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Cambridge Laboratories Limited Announces Approval of Tetrabenazine in Spain 12/8/2008 7:08:47 AM    More...
Cambridge Laboratories Limited Announces Launch Of XENAZINE(R) (Tetrabenazine) In The US 12/1/2008 3:35:36 PM    More...
Cambridge Laboratories Limited Announces New Marketing Arrangements for XENAZINE® in North America 9/25/2008 4:40:10 PM    More...
Cambridge Laboratories Limited Appoints Peter Butterfield as UK Commercial Manager 9/13/2007 3:34:27 PM    More...
Valeant Pharmaceuticals International (VRX) Acquires Rights To Nabilone In United Kingdom And Europe From Cambridge Laboratories Limited; $14 Million 2/16/2007 12:37:49 PM    More...
Cambridge Laboratories Limited's XENAZINE® 25 Mg Launched In France 8/25/2006 10:38:15 AM    More...
Cambridge Laboratories Limited Announces CHMP Positive Opinion For Valtropin(TM) 2/24/2006 3:11:29 PM    More...
Prestwick Pharmaceuticals, Inc. Release: Study Published In Neurology Shows Tetrabenazine Significantly Improves Debilitating Movement Disorder Caused By Huntington's Disease 2/14/2006 12:59:28 PM    More...
Prestwick Pharmaceuticals, Inc. Acquires Rights To Commercialize Nitoman (Tetrabenazine) In Canada 10/19/2005 5:11:29 PM    More...
IDM And Cambridge Laboratories Limited Sign An Exclusive Marketing Agreement For Junovan(TM) (Mepact) In The United Kingdom And Ireland 10/19/2005 5:09:19 PM    More...